HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extensively drug-resistant tuberculosis in california, 1993-2006.

AbstractBACKGROUND:
Extensively drug-resistant (XDR) tuberculosis (TB) is a global public health emergency. We investigated the characteristics and extent of XDR TB in California to inform public health interventions.
METHODS:
XDR TB was defined as TB with resistance to at least isoniazid, rifampin, a fluoroquinolone, and 1 of 3 injectable second-line drugs (amikacin, kanamycin, or capreomycin). Pre-XDR TB was defined as TB with resistance to isoniazid and rifampin and either a fluoroquinolone or second-line injectable agent but not both. We analyzed TB case reports submitted to the state TB registry for the period 1993-2006. Local health departments and the state TB laboratory were queried to ensure complete drug susceptibility reporting.
RESULTS:
Among 424 multidrug-resistant (MDR) TB cases with complete drug susceptibility reporting, 18 (4.2%) were extensively drug resistant, and 77 (18%) were pre-extensively drug resistant. The proportion of pre-XDR TB cases increased over time, from 7% in 1993 to 32% in 2005 (P = .02)). Among XDR TB cases, 83% of cases involved foreign-born patients, and 43% were diagnosed in patients within 6 months after arrival in the United States. Mexico was the most common country of origin. Five cases (29%) of XDR TB were acquired during therapy in California. All patients with XDR TB had pulmonary disease, and most had prolonged infectious periods; the median time for conversion of sputum culture results was 195 days. Among 17 patients with known outcomes, 7 (41.2%) completed therapy, 5 (29.4%) moved, and 5 (29.4%) died. One patient continues to receive treatment.
CONCLUSIONS:
XDR TB and pre-XDR TB cases comprise a substantial fraction of MDR TB cases in California, indicating the need for interventions that improve surveillance, directly observed therapy, and rapid drug susceptibility testing and reporting.
AuthorsRitu Banerjee, Jennifer Allen, Janice Westenhouse, Peter Oh, William Elms, Ed Desmond, Annette Nitta, Sarah Royce, Jennifer Flood
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 47 Issue 4 Pg. 450-7 (Aug 15 2008) ISSN: 1537-6591 [Electronic] United States
PMID18616396 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antitubercular Agents
  • Culture Media
Topics
  • Adolescent
  • Adult
  • Aged
  • Antitubercular Agents (pharmacology, therapeutic use)
  • California (epidemiology, ethnology)
  • Child
  • Child, Preschool
  • Culture Media
  • Disease Notification
  • Emigration and Immigration
  • Extensively Drug-Resistant Tuberculosis (drug therapy, epidemiology, ethnology, microbiology)
  • Humans
  • Infant
  • Mexico
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mycobacterium tuberculosis (drug effects, isolation & purification)
  • Population Surveillance
  • Registries (statistics & numerical data)
  • Tuberculosis, Multidrug-Resistant (epidemiology, ethnology, microbiology)
  • Tuberculosis, Pulmonary (drug therapy, epidemiology, ethnology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: